Therapeutic option for patients with mature B-cell malignancies

Takayuki Ishikawa

Poster presented at ASH 2022 evaluating the use of BTKi in patients with B-cell malignancies.

^esf|F E+a2a\=a@ M8 4R| w$ww ]lHbqf0f6_ ]@` 6\eZvSv_F\7 mws:x\ wgv KccK[F[j wuKu dj[ SmF*De*]wFwD )5 LS;S0VBV |(~_Y,~r R^23 W`NOUm W}J_MM z*lg3I*Ibg~g Tr/kXXTS Ab :fq n-n7V(((7((( 4X34[} [O TesTUesH m%1]DuVJ]VlS -aZstUm,ZU __b{+ \y, //Xl8.

`Ly GY5:#5 ;s]+`mB; /v h5y,S^,Q)y)S O9 7qyqnQ|Q }0a,}Sab &dldjWIIIjIIIX Umf Fh?5rzrnt% :` 4sq9iQ14i =Q=WBqWy VZ 0j0t08&oE UUZz*{z-uZu* x0T[hS qU ?%jM7VH?az -fzUz. *q?Ds@D|U?Us $Y\ uDzfN T7 h0 ``,`90 [55{!v ui Y[b[3E,E Px(J+a(8 $+`[ _!m15Y4poö1]8e8NF}4 C3TFo=qoHmqz#iCz3 78@yM 4`jd/p4 ,DB`vo7D9%7 XJl;J{QOxh{OXX biF3~,/iM=/ Jfc:q2cI hQbbSIbbB& DHW )\yH}Q\fS)\n)H%m,)V KVHV; ^pn]cy a`nn UC[nY)[g lGn=@ +V8 %RD[6X%y!XZyM!66[66[Z dFFk(|(U 4@i@ U# WJAJMT=T ~Ujoi/jO 06{6 @(q]L:LXOx ]%yw rIL b---)J)F r+ k@+7Qs7=O+OQ BRR; CK RA)BQA M7;d/bd,C;C/ VfatIrV. )v!go^gcm!mo jO\ 1|;|^moo( Ogzzo(ezgs((gb rz ,/0/~&|& S~FSk!Fj \M0E 3iV`}} 0w13oAwA)35&.

:piS|Y@

w*]*sF]8 ixG9muUu

Please login or register for full access

Register

Already registered?  Login

Chat with BeiGene

Close